Position in DNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,854,339
+$3,281,783 QoQ
Shares Held
691,659
+18.7% QoQ
Ownership
1.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 183 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Sep 30, 2023CallValue
$23,530
CallShares
325
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. DNA ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in DNA
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,854,339 | 691,659 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,572,556 | 582,799 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,067,061 | 489,418 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $3,828,079 | 262,557 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,509,504 | 311,956 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,610,909 | 282,616 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,793,925 | 386,347 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $136,428 | 16,740 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 DNABW | — | 25,213 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $157,845 | 472,595 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 DNABW | — | 20,396 | Shares | Sole | 2024-05-13 | |
| 2024-03-31 | $708,291 | 610,597 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 DNABW | — | 50 | Shares | Sole | 2024-02-09 | |
| 2023-12-31 | $374,525 | 221,613 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $23,530 | 13,000 | Call | Defined | 2023-11-09 | |
| 2023-09-30 | $733,136 | 405,048 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $479,673 | 257,889 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 DNABW | — | 8,082 | Shares | Sole | 2023-05-12 | |
| 2023-03-31 | $262,304 | 197,222 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 DNABW | — | 9,354 | Shares | Sole | 2023-02-08 | |
| 2022-12-31 | $560,761 | 331,812 | Shares | Defined | 2023-02-08 | |
| 2022-12-31 | $253,500 | 150,000 | Put | Defined | 2023-02-08 | |
| 2022-09-30 DNABW | — | 40,353 | Shares | Sole | 2022-11-10 | |
| 2022-09-30 | $955,932 | 306,389 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 DNABW | — | 50,576 | Shares | Sole | 2022-08-10 | |
| 2022-06-30 | $153,828 | 64,634 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $410,725 | 101,917 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 DNABW | — | 1,220 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $21,223 | 2,554 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 DNABW | — | 506 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $21,314 | 1,839 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||